Dan Vickery
President & CEO,
Vaneltix Pharma, Inc.
United States
Dr. Vickery is an experienced pharmaceutical executive with a background in pharmaceutical management and consulting. His backgorund includes senior corporate business and commercial development positions at Mylan Pharmaceuticals, Inc., and Pharmacia, Inc., including world-wide Head of Commercial Development for Women’s Health Care and Urology, and senior regulatory affairs positions at Kabi Pharmacia, Inc., and Warner-Lambert Inc. Prior to joining the Board of Vaneltix and eventually leading the company, he founded BioEnsemble, LLC a pharmaceutical business development consultancy, with global assignments in many therapeutic areas and special dosage forms. Dr. Vickery is an advisory board member of the Center for Molecular Medicine and Therapeutics, and a past board member of the Interstitial Cystitis Association.
Suffix
PhD
Sessions
-
10-Feb-2025